Evidence map›Paper›PMID 39876836›Full record

ArticleMolecular genetics & genomic medicine2025

A Novel Variant in TUBB4B Causes Progressive Cone-Rod Dystrophy and Early Onset Sensorineural Hearing Loss.

Margherita Scarpato, Francesco Testa, Anna Nesti, Roberta Zeuli, Rosa Boccia, Gennaro Auletta, Sandro Banfi, Francesca Simonelli, Marianthi Karali

Abstract readCase Reports
In one paragraph

Article in Molecular genetics & genomic medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Margherita ScarpatoMedical Genetics, Department of Precision Medicine, University of Campania 'Luigi Vanvitelli', Naples, Italy.ORCID https://orcid.org/0009-0006-7367-7911
Francesco TestaMultidisciplinary Department of Medical, Surgical and Dental Sciences, Eye Clinic, University of Campania 'Luigi Vanvitelli', Naples, Italy.ORCID https://orcid.org/0000-0002-1482-1577
Anna NestiMultidisciplinary Department of Medical, Surgical and Dental Sciences, Eye Clinic, University of Campania 'Luigi Vanvitelli', Naples, Italy.
Roberta ZeuliMedical Genetics, Department of Precision Medicine, University of Campania 'Luigi Vanvitelli', Naples, Italy.
Rosa BocciaMultidisciplinary Department of Medical, Surgical and Dental Sciences, Eye Clinic, University of Campania 'Luigi Vanvitelli', Naples, Italy.
Gennaro AulettaDepartment of Neuroscience, Reproductive Science and Dentistry, University of Naples Federico II, Naples, Italy.
Sandro BanfiMedical Genetics, Department of Precision Medicine, University of Campania 'Luigi Vanvitelli', Naples, Italy.
Francesca SimonelliMultidisciplinary Department of Medical, Surgical and Dental Sciences, Eye Clinic, University of Campania 'Luigi Vanvitelli', Naples, Italy.
Marianthi KaraliMedical Genetics, Department of Precision Medicine, University of Campania 'Luigi Vanvitelli', Naples, Italy.ORCID https://orcid.org/0000-0003-0757-3330

Funding

Ministero dell'Università e della Ricerca
6 · The paper itself

Abstract

backgroundSensorineural hearing loss (SNHL) is a frequent manifestation of syndromic inherited retinal diseases (IRDs), exemplified by the very rare form of autosomal-dominant Leber congenital amaurosis with early onset deafness (LCAEOD; OMIM #617879). LCAEOD was first described in 2017 in four families segregating heterozygous missense mutations in TUBB4B, a gene encoding a β-tubulin isotype. To date, only eight more families with similar TUBB4B-associated sensorineural disease (SND) have been reported. Most cases harbored missense variants affecting the same amino acid (Arg391) and only three families segregated variants involving different residues (Tyr310, Arg390).

methodsWe performed whole-exome sequencing and a full ophthalmological and audiological examination of the affected members in an Italian family segregating syndromic IRD with early onset deafness.

resultsWe identified a novel, ultra-rare, disease-causing variant in TUBB4B (NM_006088.6:c.1049A>C) that replaces a highly conserved lysine with threonine at amino acid position 350. The functional impact of the Lys350Thr substitution was supported by protein structure modeling studies. The variant segregates in the family members presenting retinal disease with early onset SNHL. Detailed ophthalmological assessment of the affected subjects diagnosed a progressive cone-rod dystrophy.

conclusionThese findings expand the limited number of disease-causing TUBB4B variants, corroborating their association with SND forms, and suggest Lys350 is an important residue for β-tubulin function. Interestingly, our results demonstrate that TUBB4B mutations can cause cone-dominated retinal phenotypes.

Indexed as

Cone-Rod DystrophiesHearing Loss, SensorineuralMutation, MissenseTubulinAdultFemaleHumansInfant, NewbornMalePedigreeYoung AdultTubulinprogressive cone‐rod dystrophysensorineural hearing losssyndromic inherited retinal diseaseTUBB4B

Identifiers

PMID39876836
PMCPMC11775458

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.